News

Join the Zynex, Inc. Class Action with The Gross Law Firm

Join the Zynex, Inc. Class Action with The Gross Law Firm

Contact the Gross Law Firm to Join Class Action Against Zynex, Inc.

The Gross Law Firm is reaching out to shareholders of Zynex, Inc. (NASDAQ: ZYXI) regarding an important class action. Shareholders who acquired shares during a certain period are encouraged to reach out to explore potential lead plaintiff appointments. Notably, being designated a lead plaintiff is not a prerequisite to receiving any recovery associated with the case.

Important Class Period and Allegations

The relevant class period spans from March 13, 2023, to March 11, 2025. Allegations brought forth indicate that during this time frame, Zynex issued statements that were found to be materially misleading or false, which ultimately affected shareholders. Key allegations include accusations that Zynex shipped more products than necessary, leading to inflated revenues. Such practices drew scrutiny and concerns from insurers, including military health programs.

Details on the Allegations

Particularly, it was suggested that Zynex’s approach of submitting questionable claims raised alarms, increasing the likelihood of facing adverse repercussions. These could potentially include exclusion from insurance networks and penalties from governmental authorities. These circumstances raised significant questions about the veracity of Zynex's positive outlook on its business and operational practices, which may not have been accurately assessed.

Critical Deadline for Shareholders

The deadline for shareholders to act is May 19, 2025. It is crucial for shareholders not to postpone their registration for this class action. The Gross Law Firm offers an efficient platform for shareholders to register their details, ensuring they receive timely updates throughout the case’s progression.

Next Steps and Participation

Upon registration, shareholders who purchased ZYXI shares during the outlined period will gain access to an effective portfolio monitoring system that provides updates about the case. It is important to note that the deadline for those wishing to apply as lead plaintiffs is also set for May 19, 2025. Getting involved has no cost or obligations for the shareholders.

Why Choose the Gross Law Firm?

The Gross Law Firm stands as a prominent player in the domain of class action litigation, dedicated to safeguarding the rights of investors. Their mission focuses on advocating for those who have faced losses due to misleading business practices. The firm actively promotes accountability among companies, ensuring adherence to ethical business standards and responsible actions.

Firm’s Commitment to Investors

Through their efforts, The Gross Law Firm seeks recovery for investors who were adversely impacted due to misleading information that artificially inflated a company's stock. They are committed to fostering an environment where businesses operate transparently and honorably.

Contact Information for Further Assistance

If you are interested in pursuing this class action or have further inquiries, you can reach out directly to The Gross Law Firm. Their office is located at 15 West 38th Street, 12th floor. You can also contact them via phone at (646) 453-8903 for more details. Their team is ready to assist you with the registration process and any questions you might have.

Frequently Asked Questions

What is the class action about?

The class action pertains to allegations against Zynex, Inc. regarding misleading statements that materially impacted shareholders.

Who can participate in the class action?

Shareholders who bought ZYXI shares during the specified class period are eligible to participate.

What is the deadline to join?

The deadline for shareholders to register for the class action is May 19, 2025.

Is there a cost to join the class action?

No, there is no cost or obligation to shareholders who choose to participate in the class action.

How can I contact The Gross Law Firm?

You can contact The Gross Law Firm at their office or call them directly for assistance in joining the class action.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 6

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

CTS Corporation's Q3 2024 Financial Performance Overview

Updated Category News Views 51

CTS Corporation Reports Improved Q3 2024 Results LISLE, Ill. — CTS Corporation (NYSE: CTS), a premier global designer and manufacturer of custom engineered solutions, has successfully recorded its third quarter results for 2024. Financial Highlights for Q3 2024 In the latest quarter, CTS highlighted several important financial metrics for investors: Sales amounted to...

Continue Reading
Adrian Cousins Steps Up as Head of London Market Claims at WTW

Updated Category News Views 154

Adrian Cousins Takes Lead Role at WTW WTW has recently announced the appointment of Adrian Cousins as the new Head of London Market Claims. This decision marks a significant step in the company's ongoing commitment to enhancing its claims strategy within the London market. Cousins, who has proven leadership skills and extensive experience in the industry, is set to take...

Continue Reading
Innovative Virtual Reality Solution for Remote Testing Licenses

Updated Category News Views 171

Revolutionizing Testing with Virtual Reality In today's fast-paced world, the need for innovative solutions has never been greater. One inventor from the heart of the United States has set out to address a significant challenge: testing for licenses and certifications. Introducing the C Z 2 O Z V R HUBS, an inventive virtual reality system designed for individuals seeking...

Continue Reading
New Edge Living Enhances CDA National Reserve with Luxurious Upgrades

Updated Category News Views 299

Transformative Enhancements at CDA National Reserve New Edge Living, a leader in innovative real estate development, has marked a significant evolution at CDA National Reserve, a premier private residential club that promises an exceptional blend of lifestyle and luxury. This sprawling 1,000-acre sporting and wellness destination aims to redefine the modern club...

Continue Reading
Kuros Biosciences Boosts Growth Forecast Amid Strong Sales Report

Updated Category News Views 211

Kuros Biosciences Enhances 2025 Growth Projections Kuros Biosciences, a frontrunner in the field of innovative biologic technologies, recently announced a remarkable financial performance. The company recorded a 77% increase in revenue for the first nine months of the year, solidifying its position in the market. Impressive Financial Results In just the first three...

Continue Reading